RXST
RXST
NASDAQ · Health Care

Rxsight Inc

$4.99
+0.16 (+3.31%)
As of Nov 18, 8:30 PM ET ·
Financial Highlights (FY 2026)
Revenue
151.10M
Net Income
-43,754,402
Gross Margin
76.6%
Profit Margin
-29.0%
Rev Growth
+40.0%
D/E Ratio
0.00
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 76.6% 76.6% 56.0% 56.0%
Operating Margin -35.8% -32.3% 19.2% 20.8%
Profit Margin -29.0% -27.5% 16.8% 12.9%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 151.10M 107.93M 45.49M 50.58M
Gross Profit 115.74M 82.67M 25.48M 28.33M
Operating Income -54,152,684 -34,812,439 8.73M 10.51M
Net Income -43,754,402 -28,127,829 7.66M 6.55M
Gross Margin 76.6% 76.6% 56.0% 56.0%
Operating Margin -35.8% -32.3% 19.2% 20.8%
Profit Margin -29.0% -27.5% 16.8% 12.9%
Rev Growth +40.0% +40.0% +1.5% +13.9%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 33.4K 33.4K 28.42M 28.12M
Total Equity 111.50M 111.50M 288.95M 248.82M
D/E Ratio 0.00 0.00 0.10 0.11
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -54,108,953 -36,716,789 11.61M 13.24M
Free Cash Flow — — 5.18M 4.95M